Skip to Content

APO LMV 150 (Lamivudine 150 mg)

Pill with imprint APO LMV 150 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Apotex Inc..

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO LMV 150

Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150 Front
Lamivudine 150 mg APO LMV 150 Back
Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150

Lamivudine

Imprint
APO LMV 150
Strength
150 mg
Color
White
Size
14.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Inc.
Inactive Ingredients
lactose anhydrous, crospovidone, silicon dioxide, hypromelloses, hydroxypropyl cellulose (type h), magnesium stearate, polyethylene glycol, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
60505-3251 Apotex Corp.
00904-6583 Major Pharmaceuticals

Get help with Imprint Code FAQs.

Related Images for "APO LMV 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.